NYSE: EW · Health Technology
Which UK funds hold Edwards Lifesciences Corporation (EW)?
Edwards Lifesciences Corporation (EW) is among the ten largest holdings of 1 UK fund Fundology covers, according to the holdings each fund publishes. The largest weight is 10.74%, in CYBG (VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD), as of 06/11/2026. In all, 162 funds list it among their published holdings. 37 swap-based funds also list Edwards Lifesciences Corporation (EW) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.
UK funds that hold Edwards Lifesciences Corporation
Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.
| Fund | Weight in the fund | Holdings as of |
|---|---|---|
| CYBG · VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USDIE0005TF96I9 | 10.74% |
Holdings dates differ by fund
Funds that hold it further down
161 more funds list Edwards Lifesciences Corporation below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is listed on NYSE under the symbol EW, in the health technology sector. Its market value was about $61.6bn (in US dollars) on 13/11/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above is drawn from the funds’ published holdings, each dated, and names the funds where Edwards Lifesciences Corporation is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Edwards Lifesciences Corporation without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- $107.15
- +1.28%on the day
- 52-week range
- $74.66–$107.69
- Price change, 1 year
- +25.9%
- Price change, this year
- +25.4%
- Market value
- $61.6bn
- Price to earnings (12 months)
- 62.4
- Dividend yield (12 months)
- 0.00%
As of , at least 15 min delayed